Mutational signatures can reveal properties of underlying mutational processes and are important when assessing signals of selection in cancer. Here we describe the sequence characteristics of mutations induced by ultraviolet (UV) light, a major mutagen in several human cancers, in terms of extended (longer than trinucleotide) patterns as well as variability of the signature across chromatin states. Promoter regions display a distinct UV signature with reduced TCG>TTG transitions, and genome-wide mapping of UVB-induced DNA photoproducts (pyrimidine dimers) showed that this may be explained by decreased damage formation at hypomethylated promoter CpG sites. Further, an extended signature model encompassing additional information from longer patterns improves modeling of UV mutation rate, which may enhance discrimination between drivers and passenger events. Our study presents a refined picture of the UV signature and underscores that the characteristics of a single mutational process may vary across the genome.
INTRODUCTION
Cancer is caused by somatic mutations that alter cell behavior, and the mutational processes that shape tumor genomes are therefore at the core of the disease 1 . Elucidation of such processes and their sequence preferences can provide clinically relevant insights 2, 3 and also allows improved estimation of expected mutation frequencies at recurrently altered positions, which is key when identifying driver events that are under positive selection 4 . A useful approach to discovering and characterizing mutational processes are trinucleotide-based mutational signatures, which describe the probability of mutagenesis at all possible trinucleotide sequence contexts for a given process, normally determined at the whole genome or exome level 5 . However, as cancer sequencing cohorts grow larger, even small errors in our understanding of mutation rate heterogeneity across the genome can lead to false signals of positive selection 6 , motivating an increasingly more detailed understanding of mutational processes and their sequence characteristics.
Specifically in the case of ultraviolet (UV) light, the main mutational process in melanoma and other skin cancers 5 , prior work suggests that the widely adopted trinucleotide model is inadequate.
The main basis for UV mutagenesis is the formation of cyclobutane pyrimidine dimers (CPDs) or, at lower frequency, (6,4) photoproducts (6,4-PPs); bulky DNA lesions that bridge neighboring pyrimidines and that may result in C>T or CC>TT transitions 7, 8 . The canonical UV mutational signature ("Signature 7") is consequently dominated by C>T substitutions at dipyrimidine-containing trinucleotides 5 . However, studies of UV-induced DNA damage in melanoma exome data 9 as well as smaller target templates 10, 11 support that presence of thymines in positions beyond the immediate neighboring bases may confer elevated mutation rates. Additionally, it is known that ETS transcription factor binding site sequences (TTCCG) are associated with strongly elevated CPD formation and mutation rates in melanoma, but only in promoter regions and notably at positions that are variable relative to the motif [12] [13] [14] [15] . These intricacies of the underlying mutational process may contribute to recurrent mutations in skin cancers, but cannot be captured using trinucleotide-based UV mutational signatures.
Here, we characterize the sequence signature of somatic mutations arising from UV photoproduct formation, in terms of trinucleotide and extended (beyond trinucleotide) patterns that carry information about mutation rates. We also study variability in these patterns across chromatin states. To gain mechanistic insight, we further generate the first human genome-wide map of CPDs arising from UVB, the main inducer of DNA photolesions in sunlight, which differs in its effects on DNA compared to UVC used in earlier studies. Our results constitute a refined picture of the UV mutational signature and its variability across the genome, with possible implications for the interpretation of recurrent mutations in cancer.
RESULTS

A large compendium of predominantly UV-induced somatic SNVs
While most cancer genomes are mosaics of somatic mutations induced by different processes, the study of UV-induced mutations is facilitated by their dominance and abundance in skin cancers. Here, we selected a subset of 130 "high-UV" melanoma whole genomes from an initial set of 221 samples assembled from published studies 16, 17 , excluding those with lower burden (<10,000 mutations) or lower fraction UV photoproduct-type mutations (<80 % C>T or CC>TT in a dipyrimidine context; Whole genome somatic mutation data from 221 melanomas was initially assembled from earlier studies 16, 17 and a subset of 130 samples with high burden (≥10,000 mutations) and with a high fraction (≥80%) of mutations having characteristics of UV photoproduct formation (C>T in a dipyrimidine context or CC>TT) were included for further study. TCGA, The Cancer Genome Atlas; AMPG, Australian Melanoma Genome Project. Expectedly, single nucleotide variants (SNVs) in the resulting dataset were predominantly C>T (87%) with a trinucleotide signature closely resembling the canonical UV signature ("Signature
7"
5 ), where TCG and TCC (mutated base underscored) has the highest mutation probabilities after normalization for genomic trinucleotide frequencies (Fig. 1b-c) . 99.5% of C>T mutations, which we
give particular focus in this study, were in dipyrimidine contexts, consistent with the vast majority being canonical UV photoproducts mutations. This established a large (19.7×10 6 SNVs) compendium of primarily UV-induced mutations to facilitate further study of their sequence properties. C>G  C>T  T>A  T>C  T>G   C>T   ACA  ACC  ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT   0 Fig.   1 ). Specifically, principal components analysis (PCA) appeared to separate the signatures based on whether the corresponding regions were related to transcription start sites (TSSs)/promoters, with E1
("Active TSS") and E15 ("Quiescent/low") representing opposite extremes along the first component (Fig. 2a) . Further, non-TSS-related states, encompassing the vast majority (98.7%) of the genome,
showed strong similarity to the canonical UV "Signature 7" 5 while TSS-related regions deviated (Fig.   2b ). Trinucleotide signature in promoters (500 bp upstream regions) of highly (top 25%) compared to lowly (bottom 25%) expressed genes, with TTC>TCG substitution rate being more reduced in the former category. The two sets were selected from 20,017 annotated coding genes. Examination of the signature in TSS-related regions revealed that C>T substitutions in the TCG context were notably reduced ( Fig. 2c-d) . TCG, while relatively infrequent in the genome, normally has the highest weight (highest probability of being mutated) in the normalized UV trinucleotide signature (Fig. 1c) . This may be due to facilitated CPD formation at 5-methylcytosines 21, 22 (5mC), prevalent at CpGs throughout the genome but not in promoters 23 , thus possibly also explaining the deviating signature. Consistent with this model, a recent analysis of XPC -/-cutaneous squamous cell carcinomas (cSCC) lacking global nucleotide excision repair (NER), which repairs UV photoproducts, revealed a generally reduced mutation burden in promoters explained by a reduction in YCG mutations (Y = C/T) that varied with methylation level 24 . CCG mutations, which should theoretically be similarly affected, were slightly increased rather than reduced ( Fig. 2c) , plausibly explained by its low frequency in combination with signature weights being relative rather than absolute.
In agreement with the above results, we found that promoters of annotated genes (500 bp upstream regions) displayed a similar reduction at TCG, which was more pronounced for highly compared to lowly expressed genes ( Fig. 2e) . We conclude that promoter regions show a unique UV trinucleotide signature dominated by TCC>TTC rather than TCG>TTG, possibly explained by reduced CPD formation due to decreased CpG methylation in promoters.
Local UV trinucleotide signature varies with methylation level
Next, we further investigated the relationship between trinucleotide signature and methylation levels using available whole-genome bisulfite sequencing data 20 . CpG methylation was frequent in non-TSS chromatin states (82.5% combined) but heavily reduced in TSS-related regions (11.2% in E1, "Active In annotated promoters, representing a more homogenous set compared to the ChromHMM regions, the weight for TCG>TTG in the signature correlated strongly with increasing methylation level ( Fig. 3c; Pearson's r = 0.95, P = 2.7×10 -3 ). These results further solidify a relationship between the deviating UV trinucleotide signature in promoters and reduced methylation in these regions.
Reduced pyrimidine dimer formation by UVB in promoters with reduced CpG methylation
Given the correlation between methylation level and UV signature characteristics, we next sought to directly determine whether this may be explained by differential DNA damage formation at CpGs.
Notably, it has been shown that 5mC facilitates CPD formation by UVB (280-315 nm), the main inducer of CPDs in sunlight, but not by UVC (100-280 nm) 25 To address this, we mapped CPDs genome-wide in human A375 melanoma cells immediately following exposure to UVB (310 nm), using a protocol based on T4 endonuclease V digestion and Illumina sequencing as described previously for UVC 15 ( Fig. 4a) . Two independent maps were generated, and previously published CPD data for UVC (254 nm), generated by the same protocol, were included for comparison 15 . CPDs were preferably detected at TT, TC, CT and CC dinucleotides as expected, notably with lower TT and higher CC frequencies relative to UVC, further supporting that the two wavelength ranges are not physiologically equivalent (Fig. 4b) . Interestingly, an elevation at CG, weak compared to the dipyrimidines but observed in all conditions including non-UV controls, was found to be methylation-dependent, suggesting occasional T4 endonuclease V cleavage at methylated CG dinucleotides (Supplementary Fig. 2) . In total 77.1 million UVB-induced CPDs were mapped to dipyrimidines throughout the genome and used for further analyses.
To compare CpG-and non-CpG-adjacent dipyrimidines in terms of CPD formation, we determined "CPD trinucleotide signatures" describing relative CPD frequencies across patterns consisting of a CPD-forming dipyrimidine plus one additional 3ʹ base. Genome-wide, these signatures differed markedly between UVB and UVC, as expected given the differences in dinucleotide distribution ( Supplementary Fig. 3 ).
Next, we compared highly expressed promoters to non-promoters in terms of CPD signature.
Importantly, the former were characterized by reduced CPD formation at YCG (CPD underscored) specifically for UVB but not UVC, thus confirming reduced UVB-induced DNA damage at CpGs in promoters (Fig. 4c) . A similar UVB-specific pattern was observed when comparing highly to lowly methylated genomic regions (Supplementary Fig. 2) . Likewise, across ChromHMM regions, the general trend was for UVB CPD frequency at YCG to increase with increasing methylation (r = 0.70, P = 1.5×10 -5 ; Fig. 4d ). Finally, across annotated promoters there was a strong correlation between methylation level and YCG CPD formation specifically by UVB (r = 0.94, P = 1.0×10 -7 ; Fig. 4e ).
These results show that UVB-induced DNA damage at CpGs is reduced in promoters with reduced methylation, consistent with their deviating mutational signature.
Improved UV signature modeling by addition of longer contextual patterns
While trinucleotide patterns are informative of whether a UV photoproduct can form, thus providing key information regarding mutation probability, it is also clear that longer motifs may be important [9] [10] [11] [12] [13] [14] [15] .
These signals may in part be detectable by simply considering a larger number of patterns, or using a position weight matrix still centered at the position of interest 9 , but this will obscure longer patterns occurring at highly asymmetric or variable positions relative to the mutation [12] [13] [14] [15] . To address this, we devised an extended mutational signature model that considers the central trinucleotide as well presence/absence of longer pentamer patterns at flexible locations within a +/-10 bp context around a given position, here focusing on the predominant C>T mutations (Fig. 5a ).
Extended signatures were determined for each of the 15 ChromHMM regions as well as promoters (highly or lowly expressed) using a common set of candidate pentamer features, briefly by feature selection and fitting of a logistic regression model to randomly subsampled positions from each region (see Methods). In principle, this approach allows longer patterns to have stimulating as well as attenuating effects. Cross-validation, again based on random subsampling, showed that the addition of longer motifs consistently led to improved modeling of observed mutations compared to a regular trinucleotide model, which is equivalent to setting the number of long features to zero in the extended model ( Fig. 5b and Supplementary Fig. 4 ). The majority of uncovered motifs (pentamers or longer consensus patterns indicated by cooccurrence clustering of pentamers) were associated with increased mutation probability (odds ratio > 1), and the effects were often but not always consistent across the interrogated regions (Fig. 5c) .
TTCCG was detected specifically in promoter-related regions, with E1 ("Active TSS") and annotated active promoters in particular showing strong positive odds ratios (4.1 and 2.2, respectively, the strongest of all patterns). Elevated mutation frequency was observed in particular at bases preceding TTCCG (Fig. 5d) . These observations are consistent with a known influence from ETS transcription factor binding site sequences (TTCCG) on CPD formation efficacy, specifically in promoter regions and preferably one or two bases upstream of the motif [12] [13] [14] [15] .
In agreement with a demonstrated positive influence from flanking thymines 9-11 , we found patterns related to TTTCNT (main position with elevated mutation rate underscored), as well as other poly-T-containing motifs, to have positive weights across all regions ( Fig. 5c ; exemplified by TTTCAT and TTTCGT in Fig. 5d ). GC-rich patterns were generally informative of reduced mutation rate, but this effect was notably absent in active promoter regions (Fig. 5c) . Conceivably, this may be explained by reduced power to call somatic mutations in GC-rich regions 29 , possibly counteracted by a general increase in UV mutation rate at active GC-rich promoters 24, 30 . Notable and consistent positive and negative coefficients were also seen for ATCGT and AGTCA, respectively ( Fig. 5c-d) .
Assessment of signals of selection in cancer involves determination of expected mutation rates/probabilities, which may be improved by considering mutational signatures 4 . When applied to recurrent promoter mutations, common in melanoma 31, 32 , we found that a regular trinucleotide model failed to give higher mutation probability estimates for non-TERT recurrent sites, generally believed to be passengers [12] [13] [14] [15] , compared to TERT promoter mutations (C228T and C250T) 33, 34 , which are established drivers (Fig. 5e) . In contrast, the extended model typically gave considerably higher probabilities for the non-TERT sites compared to the TERT mutations (Fig. 5e) , primarily driven by TTCCG (ETS) elements among the former. Exceptions included UTP11L and RPS20, both lacking ETS motifs, but where C>T mutations in the RPS20 promoter generate a de novo ETS site, similar to TERT 33, 34 . Low estimated probability for an ETS-related recurrent site in the RPL29 promoter was explained by counteraction from an uncommon trinucleotide context (ACT). Our results support that consideration of longer contextual patterns in addition to trinucleotides improves modeling of UV mutations, which is beneficial when assessing recurrent mutations in cancer. Moreover, analogous to our observations regarding trinucleotides, this extended UV signature varies between chromatin states.
DISCUSSION
Earlier studies have revealed a range of mutational signatures representative of different mutational processes, and have shown that the activities of these processes vary between tumors, cancer types and genomic features 1, 18 . Here, by detailed characterization of mutations induced by UV radiation through pyrimidine dimer formation, we highlight an additional layer of complexity in the form of intragenomic heterogeneity in the trinucleotide signature characteristics of a single process. Further, we find that longer contextual patterns, which were here combined with trinucleotides into an extended signature model, are informative of mutation probability. Notably, intragenomic variability is again observed for the extended signature. Signatures are thus not static but may vary depending on genomic context, which may be considered in situations such as driver mutation detection where accurate modeling of mutation rates is important.
We specifically find that the UV trinucleotide signature deviates in promoters, primarily due to reduced TCG mutations, which was linked to methylation levels. A methylation-related reduction in mutations at promoter CpG sites has previously been noted in NER-deficient cSCC tumors, proposedly due to reduced CPD formation 24 , but an impact from this effect on the general UV signature in repair-proficient cells has to our knowledge not previously been described or quantified.
By generating the first human genome-wide map of UVB-induced CPDs, we here directly demonstrate that DNA damage is reduced at these sites. Importantly, this is not testable using existing UV damage maps generated using UVC 25, 26 , and our results support marked physiological differences between the two wavelength ranges. UVC does not penetrate the atmosphere, and previous UV damage data thus fails to accurately reflect sunlight-induced DNA damage patterns in tumors.
Incorporation of longer patterns into a signature model led to improved modelling of observed UV mutations, and our results suggest that this may be beneficial in the context of methods for evaluating signals of selection in cancer. More work is needed for full comprehension of the mechanistic basis of some of the uncovered sequence motifs. Finally, it can be noted that the analyses in this study were considerably simplified by the purity and abundance of UV mutations in skin cancers, eliminating the need for deconvolution strategies. A future prospect, requiring further methodological development, is to more broadly address hypotheses regarding intragenomic signature variability and extended sequence patterns, as these questions are relevant also to other cancers and mutational processes.
MATERIALS AND METHODS
Whole genome mutation calls
Mutation calls from the Australian Melanoma Genome Project (AMGP) whole genome sequencing cohort 16 were obtained from the International Cancer Genome Consortium's (ICGC) database 35 . These data were pooled with mutation calls from The Cancer Genome Atlas (TCGA) melanoma whole genome cohort 17 , called as described previously 32 . Population variants (dbSNP v138) were removed and in cases where multiple samples from the same patient were available, the sample with the highest median allele frequency was maintained, resulting in a total of 221 tumors. From these, a subset of 130 tumors with heavy UV mutation burden were selected for subsequent analyses (>80% dipyrimidine C>T or CC>TT and total burden >10,000 mutations).
Gene annotations and ChromHMM genome segmentation data
Gene annotations from GENCODE 36 v19 were used to define TSS positions for 20,017 uniquely mapped coding genes, disregarding chrM and considering the 5ʹ-most annotated transcripts while excluding non-coding isoforms. Promoters were defined as 500 bp regions upstream of TSSs.
Processed RNA-seq data for the TCGA subset of samples were obtained from Ashouri, et al. 37 , allowing lower and upper expression quartiles to be determined for promoters. ChromHMM 
CpG methylation analyses
Bisulfite-determined CpG methylation data from leg skin were acquired from ENCODE 39 (accession ENCFF219GCQ), and coordinates were converted from hg38 to hg19 using liftOver 40 . For methylation analyses of promoters, ChromHMM regions, and genomic bins, methylation levels were defined as the average across all CpGs in that segment, after removing CpGs below a minimum coverage threshold of 5. Segments with fewer than 5 (promoters) or 10 (genomic bins) CpGs were excluded from further analyses, while no such threshold was used for the larger ChromHMM regions.
Promoters were initially grouped by methylation level into 10 equally sized bins followed by merging of the lower 3 bins which all represented 0% methylation.
Genome-wide mapping of UVB-induced cyclobutane pyrimidine dimers
A375 cells were grown in DMEM + 10% FCS + Penicillin/streptomycin (Gibco, Carlsbad, MA) and were treated with 10,000 J/m 2 UVB 310 nm (7 mins @ 25 J/m 2 /s) using a UV-2 Ultraviolet radiation system (Tyler Research Corporation, Canada) in duplicates (UVB 1 and UVB 2), and DNA from untreated cells was isolated as a control (No UV). Appropriate UVB dose was determined by T4 endonuclease V (NEB) digestion followed by analysis on a 1% alkaline gel (Supplementary Fig.   5 ). CPD sequencing then proceeded as described in Elliott, et al. 15 . All adapter oligos, including additional indexes used, are indicated in Supplementary Table 2 . The indexed libraries were pooled and sequenced with a NextSeq 500 using the High Output kit (Illumina, San Diego CA). The data has been deposited in GEO under accession GSE127966. Existing UVC CPD data (UVC1, UVC2, No UV1, No UV2) was obtained from Elliott, et al. 15 .
CPD bioinformatics
FastQ files were aligned with Bowtie 2 version 2. ratios, used to compare CPD signatures between conditions, were calculated based on these scaled weights.
Analysis of trinucleotide and extended mutational signatures
Trinucleotide signatures were determined and presented in normalized form throughout the study, dividing observed mutation counts by local genomic trinucleotide counts followed by scaling of signatures weights such that they sum to one. For a given genomic site, the corresponding weight can be interpreted as the relative probability for mutagenesis at this position.
Logistic regression was used to model the impact of longer contextual pentamer patterns, occurring within a +/-10 bp region of a given position, on mutation probability. These were considered in addition to trinucleotide patterns in the same model. We here focused on the predominant C>T substitutions, but other substitution types can in principle easily be accounted for using multinomial logistic regression. Only cytosine positions were thus considered, taking both strands into account, with a binary response variable indicating whether a mutation was detected or not at each position. The explanatory variables, all binary indicating presence/absence of specific patterns, consisted of all possible trinucleotide contexts plus a limited set of pentamer motifs determined during a feature selection step. It can be noted that, if the number of contextual patterns is set to zero and the resulting regression weights are transformed to frequency space, the resulting signature is equivalent to the genome-normalized trinucleotide signature described above.
To select a common set of long features to be used across all analyzed regions, Fisher's exact tests was used to test for motifs that were enriched or depleted at mutated positions. 500 kb random subsets of cytosine positions were analyzed this way for each ChromHMM region, and the highest- 
